| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 7.01e-05 | 26 | 173 | 4 | GO:0050431 | |
| GeneOntologyCellularComponent | nuclear body | ATMIN HHEX SP100 BMP2K E2F7 DZIP1 BCL6 SRCAP KMT2E SFMBT2 FBXL4 THOC6 PPARGC1A CCNB3 SIMC1 MKI67 SGO2 ENG KNL1 | 1.82e-04 | 903 | 173 | 19 | GO:0016604 |
| GeneOntologyCellularComponent | rod spherule | 2.03e-04 | 3 | 173 | 2 | GO:0044317 | |
| HumanPheno | Milia | 3.94e-05 | 17 | 61 | 4 | HP:0001056 | |
| HumanPheno | Hypoplasia of the middle phalanges of the hand | 4.22e-05 | 55 | 61 | 6 | HP:0010240 | |
| HumanPheno | Short middle phalanx of finger | 4.22e-05 | 55 | 61 | 6 | HP:0005819 | |
| HumanPheno | Atrophic scars | 6.77e-05 | 37 | 61 | 5 | HP:0001075 | |
| HumanPheno | Aplasia/Hypoplasia of the middle phalanges of the hand | 8.38e-05 | 62 | 61 | 6 | HP:0009843 | |
| MousePheno | abnormal pharyngeal arch morphology | HHEX MDH1 PTCH1 ITGAV SFMBT2 PRDM1 CCM2 IPO9 SH3PXD2A AKAP13 ENG | 1.75e-06 | 171 | 146 | 11 | MP:0002884 |
| MousePheno | abnormal craniofacial development | IFT140 HHEX ZEB1 LAMA3 MDH1 PTCH1 ITGAV SFMBT2 LUZP1 PRDM1 CCM2 IPO9 SH3PXD2A AKAP13 ENG | 3.82e-05 | 425 | 146 | 15 | MP:0003935 |
| MousePheno | abnormal craniofacial morphology | ATMIN NDST1 IFT140 HHEX ZEB1 LAMA3 LAMB3 CILK1 MDH1 PTCH1 UBN2 ITGAV DCAF5 SFMBT2 LUZP1 PRDM1 EBF2 CCM2 IPO9 DST SH3PXD2A GORAB LRP2 AKAP13 CFAP70 PEAK1 LRBA MBD5 ENG KDM6A | 7.00e-05 | 1372 | 146 | 30 | MP:0000428 |
| MousePheno | craniofacial phenotype | ATMIN NDST1 IFT140 HHEX ZEB1 LAMA3 LAMB3 CILK1 MDH1 PTCH1 UBN2 ITGAV DCAF5 SFMBT2 LUZP1 PRDM1 EBF2 CCM2 IPO9 DST SH3PXD2A GORAB LRP2 AKAP13 CFAP70 PEAK1 LRBA MBD5 ENG KDM6A | 7.00e-05 | 1372 | 146 | 30 | MP:0005382 |
| MousePheno | abnormal Harderian gland porphyrin secretion | 1.08e-04 | 2 | 146 | 2 | MP:0013476 | |
| MousePheno | abnormal Harderian gland physiology | 1.08e-04 | 2 | 146 | 2 | MP:0003859 | |
| MousePheno | decreased ovary weight | 1.13e-04 | 46 | 146 | 5 | MP:0004856 | |
| Domain | COE | 2.94e-06 | 4 | 170 | 3 | PS01345 | |
| Domain | Transcription_factor_COE | 2.94e-06 | 4 | 170 | 3 | IPR003523 | |
| Domain | COE_HLH | 2.94e-06 | 4 | 170 | 3 | IPR032201 | |
| Domain | COE_DBD | 2.94e-06 | 4 | 170 | 3 | IPR032200 | |
| Domain | Transcription_factor_COE_CS | 2.94e-06 | 4 | 170 | 3 | IPR018350 | |
| Domain | COE1_HLH | 2.94e-06 | 4 | 170 | 3 | PF16423 | |
| Domain | COE1_DBD | 2.94e-06 | 4 | 170 | 3 | PF16422 | |
| Domain | Znf_piccolo | 8.24e-05 | 2 | 170 | 2 | IPR008899 | |
| Domain | zf-piccolo | 8.24e-05 | 2 | 170 | 2 | PF05715 | |
| Domain | IPT | 9.87e-05 | 27 | 170 | 4 | SM00429 | |
| Domain | GFP-like | 1.16e-04 | 11 | 170 | 3 | IPR023413 | |
| Domain | - | 1.16e-04 | 11 | 170 | 3 | 2.40.155.10 | |
| Domain | EGF_CA | 1.27e-04 | 122 | 170 | 7 | SM00179 | |
| Domain | EGF_CA | 1.34e-04 | 86 | 170 | 6 | PF07645 | |
| Domain | EGF-like_Ca-bd_dom | 1.41e-04 | 124 | 170 | 7 | IPR001881 | |
| Domain | TIG | 1.72e-04 | 31 | 170 | 4 | PF01833 | |
| Domain | IPT | 1.95e-04 | 32 | 170 | 4 | IPR002909 | |
| Domain | Ldl_recept_b | 2.51e-04 | 14 | 170 | 3 | PF00058 | |
| Domain | LDLRB | 2.51e-04 | 14 | 170 | 3 | PS51120 | |
| Domain | EGF_Ca-bd_CS | 2.60e-04 | 97 | 170 | 6 | IPR018097 | |
| Domain | EGF_CA | 2.90e-04 | 99 | 170 | 6 | PS01187 | |
| Domain | LY | 3.11e-04 | 15 | 170 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.11e-04 | 15 | 170 | 3 | IPR000033 | |
| Domain | Znf_FYVE_PHD | 4.00e-04 | 147 | 170 | 7 | IPR011011 | |
| Domain | ZP_dom | 4.59e-04 | 17 | 170 | 3 | IPR001507 | |
| Domain | Zona_pellucida | 4.59e-04 | 17 | 170 | 3 | PF00100 | |
| Domain | EGF_1 | 5.60e-04 | 255 | 170 | 9 | PS00022 | |
| Domain | Growth_fac_rcpt_ | 5.72e-04 | 156 | 170 | 7 | IPR009030 | |
| Domain | EGF-like_CS | 6.62e-04 | 261 | 170 | 9 | IPR013032 | |
| Domain | EGF_2 | 7.37e-04 | 265 | 170 | 9 | PS01186 | |
| Domain | NUT | 8.09e-04 | 5 | 170 | 2 | IPR024310 | |
| Domain | NUT_N | 8.09e-04 | 5 | 170 | 2 | IPR024309 | |
| Domain | NUT | 8.09e-04 | 5 | 170 | 2 | PF12881 | |
| Domain | DUF4704 | 8.09e-04 | 5 | 170 | 2 | IPR031570 | |
| Domain | DUF4704 | 8.09e-04 | 5 | 170 | 2 | PF15787 | |
| Domain | PH_BEACH | 1.21e-03 | 6 | 170 | 2 | PF14844 | |
| Domain | GAR | 1.21e-03 | 6 | 170 | 2 | PS51460 | |
| Domain | GAS2 | 1.21e-03 | 6 | 170 | 2 | PF02187 | |
| Domain | - | 1.21e-03 | 6 | 170 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 1.21e-03 | 6 | 170 | 2 | IPR003108 | |
| Domain | GAS2 | 1.21e-03 | 6 | 170 | 2 | SM00243 | |
| Domain | EGF | 1.42e-03 | 235 | 170 | 8 | SM00181 | |
| Pubmed | NOL4 ZEB1 RBBP8 USP24 MDH1 SFMBT2 LUZP1 RLF DST TLE3 LRP2 ANKRD17 CHD6 LRBA KNL1 | 4.93e-09 | 418 | 178 | 15 | 34709266 | |
| Pubmed | CILK1 GPRIN3 ZBTB26 ALPK1 RALGAPA2 UBN2 TRIM14 RUFY2 CCDC88C MYOF IPO9 POM121 SSH1 PEAK1 MBD5 | 4.37e-08 | 493 | 178 | 15 | 15368895 | |
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 9151732 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATMIN FRMPD1 ASH1L SRF LAMA3 CILK1 ZNF385B UBN2 ZP3 SNX29 SFMBT2 RLF SHANK2 SH3PXD2A TLE3 RASGEF1C ANKRD17 AKAP13 CHD6 LTBR PNPLA7 LRBA SPATS2 MBD5 KDM6A | 1.86e-07 | 1489 | 178 | 25 | 28611215 |
| Pubmed | GAK BMP2K TACC2 SNX29 DMXL1 MB21D2 DST GORAB PEAK1 MARK2 LRBA | 2.86e-07 | 285 | 178 | 11 | 34369648 | |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 9151733 | ||
| Pubmed | Cloning of a novel Olf-1/EBF-like gene, O/E-4, by degenerate oligo-based direct selection. | 5.25e-07 | 4 | 178 | 3 | 12139918 | |
| Pubmed | 8.66e-07 | 15 | 178 | 4 | 25762221 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ATMIN NDST1 KALRN LMTK2 LAMB3 ATG2A PTCH1 BCL9 SRCAP RALGAPA2 PLXNB2 CCDC88C MYOF DST SHANK2 SSH1 NBEAL2 AKAP13 LRBA MBD5 | 1.11e-06 | 1105 | 178 | 20 | 35748872 |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 12917357 | ||
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 15261831 | ||
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 23358160 | ||
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 17580084 | ||
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 9389446 | ||
| Pubmed | 3.01e-06 | 20 | 178 | 4 | 16774995 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 3.28e-06 | 231 | 178 | 9 | 16452087 | |
| Pubmed | 3.71e-06 | 21 | 178 | 4 | 27600842 | ||
| Pubmed | KDM3A IFT140 PITRM1 LMTK2 DZIP1 ATG2A STAB1 ZFYVE28 DST ACSBG1 NBEAL2 ANKRD17 BSN | 3.80e-06 | 529 | 178 | 13 | 14621295 | |
| Pubmed | Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1. | 4.54e-06 | 7 | 178 | 3 | 24786561 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | IFT140 PITRM1 COPG1 USP24 NUTM2D TRMO ALPK1 PLXNB2 KIF24 RUFY2 NUTM2E ZFYVE28 KAT2B TRAFD1 NUTM2B SH3PXD2A NBEAL2 WFIKKN2 SGO2 KCNIP4 | 6.43e-06 | 1242 | 178 | 20 | 30973865 |
| Pubmed | 6.51e-06 | 24 | 178 | 4 | 20826655 | ||
| Pubmed | 7.24e-06 | 8 | 178 | 3 | 14993187 | ||
| Pubmed | 1.06e-05 | 27 | 178 | 4 | 33760820 | ||
| Pubmed | delta-EF1 is a negative regulator of Ihh in the developing growth plate. | 1.08e-05 | 9 | 178 | 3 | 19948490 | |
| Pubmed | 1.08e-05 | 9 | 178 | 3 | 12482924 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KDM3A ZEB1 RBBP8 USP24 BCL9 RFX7 LIG1 MYOF TRAFD1 SSH1 TLE3 MKI67 ANKRD17 MARK2 KDM6A | 1.18e-05 | 774 | 178 | 15 | 15302935 |
| Pubmed | GPRIN3 DZIP1 RALGAPA2 ITGAV PLXNB2 JPH1 DST GORAB PEAK1 MARK2 LRBA | 1.22e-05 | 421 | 178 | 11 | 36976175 | |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 10. | PITRM1 EBF3 NUTM2D TACC2 SFMBT2 RUFY2 MYOF SH3PXD2A CTNNA3 MKI67 | 1.26e-05 | 345 | 178 | 10 | 15164054 |
| Pubmed | 1.43e-05 | 29 | 178 | 4 | 23499423 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.47e-05 | 351 | 178 | 10 | 38297188 | |
| Pubmed | 1.64e-05 | 30 | 178 | 4 | 30127719 | ||
| Pubmed | NOL4 IFT140 SP100 ATXN7L2 ADAMTS1 ASH1L SRCAP RALGAPA2 DCAF5 LUZP1 JPH1 KAT2B TRAFD1 CCNB3 RTL9 LRP2 ANKRD17 KNL1 | 1.87e-05 | 1116 | 178 | 18 | 31753913 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | HHEX SP100 ZEB1 EBF3 ASH1L HDX SRF E2F7 EBF1 BCL6 RFX7 SIX6 PRDM1 THAP2 NEUROD2 NPAS1 | 1.94e-05 | 908 | 178 | 16 | 19274049 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | KDM3A SP100 ZNF185 HDX TACC2 UBN2 LUZP1 PSME3IP1 PIGR TLE3 SIMC1 | 2.00e-05 | 444 | 178 | 11 | 34795231 |
| Pubmed | 2.11e-05 | 11 | 178 | 3 | 20139090 | ||
| Pubmed | Control of hindbrain motor neuron differentiation by the homeobox gene Phox2b. | 2.11e-05 | 11 | 178 | 3 | 10704382 | |
| Pubmed | Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. | 2.11e-05 | 11 | 178 | 3 | 8707838 | |
| Pubmed | 2.11e-05 | 11 | 178 | 3 | 10811835 | ||
| Pubmed | Current insights into the formation and breakdown of hemidesmosomes. | 2.11e-05 | 11 | 178 | 3 | 16757171 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 1330788 | ||
| Pubmed | Molecular analysis of cDNA coding for ZP3, a sperm binding protein of the mouse zona pellucida. | 2.60e-05 | 2 | 178 | 2 | 3378665 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 3012564 | ||
| Pubmed | Human ZP3 restores fertility in Zp3 null mice without affecting order-specific sperm binding. | 2.60e-05 | 2 | 178 | 2 | 9609824 | |
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 2.60e-05 | 2 | 178 | 2 | 23403927 | |
| Pubmed | HHEX suppresses advanced thyroid cancer by interacting with TLE3. | 2.60e-05 | 2 | 178 | 2 | 37302518 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 24631505 | ||
| Pubmed | Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors. | 2.60e-05 | 2 | 178 | 2 | 23244127 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 17258189 | ||
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 2.60e-05 | 2 | 178 | 2 | 26793095 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 17007971 | ||
| Pubmed | Mapping the mouse ZP3 combining site for sperm by exon swapping and site-directed mutagenesis. | 2.60e-05 | 2 | 178 | 2 | 7816829 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 20382503 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 20332206 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 9476659 | ||
| Pubmed | Genomic organization of a sex specific gene: the primary sperm receptor of the mouse zona pellucida. | 2.60e-05 | 2 | 178 | 2 | 2535821 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 7718569 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 19788614 | ||
| Pubmed | Active zone density is conserved during synaptic growth but impaired in aged mice. | 2.60e-05 | 2 | 178 | 2 | 21935939 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 8305213 | ||
| Pubmed | Altered target organ. A mechanism of postrecovery resistance to murine autoimmune oophoritis. | 2.60e-05 | 2 | 178 | 2 | 7561067 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 1729594 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 25265234 | ||
| Pubmed | Blimp-1 attenuates Th1 differentiation by repression of ifng, tbx21, and bcl6 gene expression. | 2.60e-05 | 2 | 178 | 2 | 18684923 | |
| Pubmed | Crystal structure of the ZP-N domain of ZP3 reveals the core fold of animal egg coats. | 2.60e-05 | 2 | 178 | 2 | 19052627 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 32130892 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 8175755 | ||
| Pubmed | Structural requirement for cell adhesion to kalinin (laminin-5). | 2.60e-05 | 2 | 178 | 2 | 7775432 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 27363279 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 21241837 | ||
| Pubmed | Secretion of zona pellucida glycoprotein mZP2 by growing oocytes from mZP3(+/+) and mZP3(-/-) mice. | 2.60e-05 | 2 | 178 | 2 | 10440843 | |
| Pubmed | Mice homozygous for an insertional mutation in the Zp3 gene lack a zona pellucida and are infertile. | 2.60e-05 | 2 | 178 | 2 | 8787763 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 15128590 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 14645511 | ||
| Pubmed | A duplicated motif controls assembly of zona pellucida domain proteins. | 2.60e-05 | 2 | 178 | 2 | 15079052 | |
| Pubmed | Recombinant mouse ZP3 inhibits sperm binding and induces the acrosome reaction. | 2.60e-05 | 2 | 178 | 2 | 1577197 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 32572238 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 10603086 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 8643592 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 34792530 | ||
| Pubmed | Critical role for Ebf1 and Ebf2 in the adipogenic transcriptional cascade. | 2.60e-05 | 2 | 178 | 2 | 17060461 | |
| Pubmed | Nucleotide sequence of cDNA encoding bonnet monkey (Macaca radiata) zona pellucida glycoprotein-ZP3. | 2.60e-05 | 2 | 178 | 2 | 8848588 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 24675808 | ||
| Pubmed | Synaptic activity controls localization and function of CtBP1 via binding to Bassoon and Piccolo. | 2.60e-05 | 2 | 178 | 2 | 25652077 | |
| Pubmed | POM-ZP3, a bipartite transcript derived from human ZP3 and a POM121 homologue. | 2.60e-05 | 2 | 178 | 2 | 7789967 | |
| Pubmed | A role for Lin28 in primordial germ-cell development and germ-cell malignancy. | 2.60e-05 | 2 | 178 | 2 | 19578360 | |
| Pubmed | Polypeptide backbone derived from carboxyl terminal of mouse ZP3 inhibits sperm-zona binding. | 2.60e-05 | 2 | 178 | 2 | 17290430 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 16245311 | ||
| Pubmed | Antibodies to two ZP3 B cell epitopes affect zona pellucida assembly. | 2.60e-05 | 2 | 178 | 2 | 18420282 | |
| Pubmed | Mass spectrometry analysis of recombinant human ZP3 expressed in glycosylation-deficient CHO cells. | 2.60e-05 | 2 | 178 | 2 | 15379548 | |
| Pubmed | ZP3 is Required for Germinal Vesicle Breakdown in Mouse Oocyte Meiosis. | 2.60e-05 | 2 | 178 | 2 | 28145526 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 37392376 | ||
| Pubmed | Decreased Bcl-6 and increased Blimp-1 in the peritoneal cavity of patients with endometriosis. | 2.60e-05 | 2 | 178 | 2 | 26054109 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 24240683 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 14972104 | ||
| Pubmed | Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer. | 2.60e-05 | 2 | 178 | 2 | 26297948 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 20966935 | ||
| Pubmed | Primary structure of the mouse sperm receptor polypeptide determined by genomic cloning. | 2.60e-05 | 2 | 178 | 2 | 2842770 | |
| Pubmed | KDM3A Senses Oxygen Availability to Regulate PGC-1α-Mediated Mitochondrial Biogenesis. | 2.60e-05 | 2 | 178 | 2 | 31629659 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 27424222 | ||
| Pubmed | Biosynthesis of the sperm receptor during oogenesis in the mouse. | 2.60e-05 | 2 | 178 | 2 | 11892795 | |
| Interaction | TLE3 interactions | KDM3A HHEX HNF1B COPG1 EBF3 RBBP8 BCL9 UBN2 SVEP1 SIX6 PRDM1 POM121 TLE3 CHD6 KNL1 | 9.92e-07 | 376 | 174 | 15 | int:TLE3 |
| GeneFamily | WD repeat domain containing | 2.00e-04 | 262 | 110 | 8 | 362 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | NOL4 HNF1B ANK2 EBF3 PCLO NUTM2A LAMA3 GPRIN3 EBF1 KMT2E RFX7 UBN2 CSMD3 LRP1B RUFY2 JPH1 EBF2 PPARGC1A SHANK2 SH3PXD2A RNF146 KCNIP4 BSN PRLR | 4.21e-07 | 1106 | 176 | 24 | M39071 |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 9.31e-07 | 152 | 176 | 9 | M39243 | |
| Coexpression | ROVERSI_GLIOMA_COPY_NUMBER_DN | 1.66e-06 | 54 | 176 | 6 | M18630 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 1.05e-05 | 155 | 176 | 8 | M39246 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 1.21e-05 | 208 | 176 | 9 | M39233 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HHEX ZNF185 ASH1L GPRIN3 EBF1 GLCCI1 DCAF5 DMXL1 PRDM1 THAP2 MYOF TMTC1 DST EGF SRGN LRBA MBD5 KDM6A | 1.92e-05 | 854 | 176 | 18 | M1533 |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | SP100 BMP2K E2F7 ATG2A BCL6 CHKB ITGAV DCAF5 CCDC88C KAT2B NOP9 TRAFD1 SSH1 SH3PXD2A RNF146 GORAB AKAP13 CHD6 KDM6A | 2.05e-05 | 942 | 176 | 19 | M8144 |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP | SP100 BMP2K E2F7 ATG2A BCL6 CHKB ITGAV DCAF5 CCDC88C KAT2B SSH1 SH3PXD2A RNF146 GORAB AKAP13 CHD6 KDM6A | 2.11e-05 | 778 | 176 | 17 | M17915 |
| Coexpression | GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_DN | 2.85e-05 | 178 | 176 | 8 | M2952 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HHEX ZNF185 ASH1L GPRIN3 EBF1 GLCCI1 DCAF5 DMXL1 PRDM1 THAP2 MYOF TMTC1 DST EGF SRGN LRBA MBD5 KDM6A | 3.21e-05 | 888 | 176 | 18 | MM1018 |
| Coexpression | GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP | 5.64e-05 | 196 | 176 | 8 | M5189 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | ZEB1 PARP8 ASH1L USP24 GPRIN3 CST7 KMT2E RFX7 TRIM14 SLAMF1 GLCCI1 DCAF5 SFMBT2 LUZP1 PRDM1 ZFYVE28 CCDC88C KAT2B SSH1 SRGN NBEAL2 AKAP13 LRBA RPL17 | 6.42e-05 | 1492 | 176 | 24 | M40023 |
| Coexpression | GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP | 6.50e-05 | 200 | 176 | 8 | M6004 | |
| Coexpression | GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP | 6.50e-05 | 200 | 176 | 8 | M7446 | |
| Coexpression | GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | 6.50e-05 | 200 | 176 | 8 | M7432 | |
| Coexpression | PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7 | SP100 KALRN ZNF185 E2F7 PTCH1 SRCAP GLCCI1 MYOF AKAP13 MMP1 PRLR | 8.62e-05 | 399 | 176 | 11 | M2413 |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP | 1.05e-04 | 339 | 176 | 10 | M34012 | |
| Coexpression | GSE13547_WT_VS_ZFX_KO_BCELL_UP | 1.21e-04 | 163 | 176 | 7 | M2997 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | SYNPO2 EBF3 RBBP8 BCL9 LUZP1 EBF2 MYOF NOP9 SRGN SIMC1 MKI67 SGO2 LRBA MUC6 KNL1 | 1.38e-05 | 492 | 174 | 15 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | HNF1B SP100 PCLO ZNF185 ZNF385B BCL9 ITGAV KIF24 SNX29 LUZP1 ZFYVE28 PPARGC1A TMTC1 ACSBG1 MPZL3 SRGN WFIKKN2 MKI67 SGO2 CFAP70 PEAK1 MUC6 | 1.76e-05 | 979 | 174 | 22 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3 | MRC1 GAS2L3 CST7 DZIP1 SLAMF1 DDIAS LIG1 MPP4 MKI67 SGO2 SPATS2 ENG KNL1 | 3.89e-05 | 414 | 174 | 13 | GSM476660_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_500 | HNF1B SP100 PCLO ZNF185 ZNF385B BCL9 ITGAV SNX29 ZFYVE28 PPARGC1A ACSBG1 MPZL3 CFAP70 MUC6 | 5.22e-05 | 488 | 174 | 14 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | HNF1B SP100 NWD1 PCLO ZNF385B BCL9 ZFYVE28 MPZL3 SRGN WFIKKN2 MKI67 PEAK1 LRBA MUC6 | 5.69e-05 | 492 | 174 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_200 | 1.05e-04 | 176 | 174 | 8 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_200 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2 | HHEX PARP8 MC5R CST7 EBF1 SNX29 LIG1 MYOF MKI67 SGO2 ENG KNL1 | 1.17e-04 | 399 | 174 | 12 | GSM538345_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_200 | 1.18e-04 | 179 | 174 | 8 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#4 | SP100 ZNF385B BCL9 SNX29 ZFYVE28 MYOF TMTC1 ACSBG1 MPZL3 SRGN WFIKKN2 AKAP13 PEAK1 MUC6 | 1.23e-04 | 529 | 174 | 14 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K4 |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_200 | 1.32e-04 | 182 | 174 | 8 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_200 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | MOK NOL4 ZEB1 TTC41P ANK2 RBBP8 PPM1E E2F7 BCL9 UBN2 KIF24 LIN28A LUZP1 RUFY2 THAP2 CCDC88C LIG1 SHANK2 ACSBG1 SRGN MKI67 ETAA1 SGO2 PNPLA7 MBD5 KNL1 | 1.47e-04 | 1459 | 174 | 26 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | RBBP8 E2F7 CST7 SLAMF1 PRDM1 DDIAS LIG1 ACSBG1 NBEAL2 MKI67 SGO2 KNL1 | 1.50e-04 | 410 | 174 | 12 | GSM538387_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | MOK ANK2 RBBP8 PCLO PPM1E BCL9 KMT2E LIN28A LUZP1 JPH1 ZFYVE28 CCDC88C PPARGC1A ACSBG1 SRGN WFIKKN2 LRP2 CHD6 PEAK1 LRBA | 1.68e-04 | 983 | 174 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | kidney_e10.5_UretericTrunk_HoxB7_k-means-cluster#4_top-relative-expression-ranked_100 | 1.84e-04 | 14 | 174 | 3 | gudmap_kidney_e10.5_UretericTrunk_HoxB7_k4_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | SYNPO2 ANK2 GAS2L3 EBF3 PPM1E FRMPD1 CILK1 DZIP1 BCL6 RFX7 PRDM1 THAP2 PPARGC1A DST MICALL2 GORAB SGO2 KDM6A | 2.23e-04 | 850 | 174 | 18 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d10.LisOva, CD8+ CD45.1+, Spleen, avg-3 | SP100 GPRIN3 CST7 RALGAPA2 SLAMF1 PRDM1 CCDC88C ACSBG1 NBEAL2 WFIKKN2 PEAK1 | 2.42e-04 | 369 | 174 | 11 | GSM605891_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | MOK ZEB1 TTC41P ANK2 RBBP8 PPM1E E2F7 BCL9 UBN2 KIF24 LUZP1 RUFY2 THAP2 CCDC88C LIG1 SHANK2 ACSBG1 MKI67 ETAA1 SGO2 PNPLA7 MBD5 KNL1 | 2.53e-04 | 1257 | 174 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | SP100 GPRIN3 CST7 SLAMF1 PRDM1 CCDC88C ACSBG1 NBEAL2 WFIKKN2 MKI67 KNL1 | 2.72e-04 | 374 | 174 | 11 | GSM538389_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d15.LisOva, CD8+ CD45.1+, Spleen, avg-3 | SP100 GPRIN3 CST7 DZIP1 SLAMF1 PRDM1 CCDC88C ACSBG1 NBEAL2 WFIKKN2 PEAK1 | 2.85e-04 | 376 | 174 | 11 | GSM605894_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.96e-04 | 259 | 174 | 9 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d8.LisOva, CD8+ CD45.1+, Spleen, avg-3 | SP100 GPRIN3 CST7 RALGAPA2 SLAMF1 PRDM1 CCDC88C ACSBG1 NBEAL2 WFIKKN2 PEAK1 | 3.11e-04 | 380 | 174 | 11 | GSM605901_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp.OT1.d45.LisOva, CD8+ CD45.1+, Spleen, avg-2 | SP100 GPRIN3 CST7 DZIP1 SLAMF1 PRDM1 CCDC88C ACSBG1 NBEAL2 WFIKKN2 PEAK1 | 3.33e-04 | 383 | 174 | 11 | GSM605907_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | MOK NOL4 ZEB1 ANK2 GAS2L3 PARP8 PPM1E E2F7 PTCH1 BCL9 RALGAPA2 KIF24 RUFY2 CCDC88C LIG1 PPARGC1A TMTC1 KAT2B THBS3 TLE3 MKI67 ETAA1 KDM6A KNL1 | 3.49e-04 | 1370 | 174 | 24 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d8.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | SP100 GPRIN3 CST7 RALGAPA2 SLAMF1 PRDM1 CCDC88C ACSBG1 NBEAL2 WFIKKN2 PEAK1 | 3.63e-04 | 387 | 174 | 11 | GSM538392_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | SP100 SYNPO2 ZEB1 TTC41P PITRM1 EBF3 RBBP8 DZIP1 BCL9 TRIM14 LIN28A LUZP1 STAB1 RUFY2 DDIAS LIG1 ACSBG1 SRGN NBEAL2 MKI67 ETAA1 SGO2 LRBA KDM6A KNL1 | 3.97e-04 | 1468 | 174 | 25 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500_k-means-cluster#3 | 4.29e-04 | 118 | 174 | 6 | Facebase_RNAseq_e8.5_Floor Plate_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SP100 ZNF385B BCL9 ITGAV SNX29 ZFYVE28 MYOF TMTC1 ACSBG1 MPZL3 WFIKKN2 PEAK1 MUC6 | 4.44e-04 | 530 | 174 | 13 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2 | CST7 TACC2 DZIP1 DDIAS LIG1 ACSBG1 WFIKKN2 MKI67 SGO2 ENG KNL1 | 4.60e-04 | 398 | 174 | 11 | GSM538338_500 |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#2_top-relative-expression-ranked_100 | 4.76e-04 | 19 | 174 | 3 | gudmap_kidney_adult_Mesangium_Meis_k2_100 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#1_top-relative-expression-ranked_200 | 4.99e-04 | 45 | 174 | 4 | gudmap_kidney_adult_Mesangium_Meis_k1_200 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3 | GPRIN3 CST7 SLAMF1 PRDM1 LIG1 ACSBG1 NBEAL2 WFIKKN2 MKI67 SGO2 KNL1 | 5.00e-04 | 402 | 174 | 11 | GSM605898_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | HNF1B SP100 NWD1 PCLO ZNF385B BCL9 LUZP1 EBF2 ZFYVE28 IPO9 SSH1 MPZL3 SRGN WFIKKN2 MKI67 PEAK1 LRBA MUC6 KNL1 | 5.01e-04 | 989 | 174 | 19 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | SYNPO2 EBF3 RBBP8 DZIP1 BCL9 KMT2E LUZP1 SRGN WFIKKN2 SIMC1 RTL9 MKI67 SGO2 AKAP13 PEAK1 LRBA KNL1 | 5.17e-04 | 834 | 174 | 17 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | SYNPO2 ZEB1 ANK2 ADAMTS1 EBF1 CSMD3 SVEP1 EBF2 TMTC1 CHRDL1 C1R | 4.94e-10 | 199 | 177 | 11 | 3835452e4848d7f7dd8651c17b746b271ef39688 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.96e-09 | 190 | 177 | 10 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.77e-09 | 193 | 177 | 10 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | HNF1B RBBP8 PCLO LRP1B SNX29 PPARGC1A SHANK2 EGF KCNIP4 LRBA | 6.36e-09 | 195 | 177 | 10 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 6.68e-09 | 196 | 177 | 10 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | SP100 ADAMTS1 PARP8 USP24 CST7 PTCH1 SRCAP PRDM1 KAT2B PEAK1 | 8.11e-09 | 200 | 177 | 10 | 2281debd86e5d92e8fe0397aec9ef670800f7471 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.32e-08 | 183 | 177 | 9 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 6.11e-08 | 186 | 177 | 9 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.40e-08 | 187 | 177 | 9 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.70e-08 | 188 | 177 | 9 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.01e-08 | 189 | 177 | 9 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.33e-08 | 190 | 177 | 9 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 8.02e-08 | 192 | 177 | 9 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.39e-08 | 193 | 177 | 9 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.39e-08 | 193 | 177 | 9 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.76e-08 | 194 | 177 | 9 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.76e-08 | 194 | 177 | 9 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-07 | 199 | 177 | 9 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-MAIT|IIF / Disease, condition lineage and cell class | 1.14e-07 | 200 | 177 | 9 | 7518bbf1c713b74f89be25ee700c6b0edc16ee8a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-07 | 158 | 177 | 8 | d72d6527dc50207ddbada262460d3c4bac249a19 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-07 | 159 | 177 | 8 | 50d951cf27a571c0c5002003c16fbc370fa17eb1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.70e-07 | 181 | 177 | 8 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.99e-07 | 182 | 177 | 8 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.99e-07 | 182 | 177 | 8 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.59e-07 | 184 | 177 | 8 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 7.59e-07 | 184 | 177 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.91e-07 | 185 | 177 | 8 | 03f64a7132b13a01ba47187e0e15c13ac88f7cb2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.23e-07 | 186 | 177 | 8 | 1850583d23903d08226aeb0edb3e07b0994330e4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.23e-07 | 186 | 177 | 8 | 4dafc215c42e7949f932a3627359c107943b5d6b | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.57e-07 | 187 | 177 | 8 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.57e-07 | 187 | 177 | 8 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.57e-07 | 187 | 177 | 8 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.92e-07 | 188 | 177 | 8 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.92e-07 | 188 | 177 | 8 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.92e-07 | 188 | 177 | 8 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.92e-07 | 188 | 177 | 8 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.10e-07 | 130 | 177 | 7 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.29e-07 | 189 | 177 | 8 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 9.29e-07 | 189 | 177 | 8 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.29e-07 | 189 | 177 | 8 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.29e-07 | 189 | 177 | 8 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-07 | 190 | 177 | 8 | cc17ab84a9328124f146951c06be3eff9650d9fd | |
| ToppCell | COPD-Lymphoid|COPD / Disease state, Lineage and Cell class | 1.05e-06 | 192 | 177 | 8 | 064fefb8212fadab0ff441f4bf643559b7fdb25d | |
| ToppCell | Control-Lymphoid-T|World / Disease state, Lineage and Cell class | 1.05e-06 | 192 | 177 | 8 | 253cf4d2cf88ad8c45b73779336180840bef054b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.05e-06 | 192 | 177 | 8 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 1.05e-06 | 192 | 177 | 8 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 1.09e-06 | 193 | 177 | 8 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-06 | 193 | 177 | 8 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.09e-06 | 193 | 177 | 8 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-06 | 193 | 177 | 8 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-06 | 194 | 177 | 8 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.17e-06 | 195 | 177 | 8 | 31b011f3d54e6729802aad1f771cef77744e3ff2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-06 | 195 | 177 | 8 | d35102f95bb1e419d2df05ff0a01b6c5c923acef | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.17e-06 | 195 | 177 | 8 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-06 | 196 | 177 | 8 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-06 | 196 | 177 | 8 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.27e-06 | 197 | 177 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 197 | 177 | 8 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 197 | 177 | 8 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 197 | 177 | 8 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 197 | 177 | 8 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-T_mait-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.27e-06 | 197 | 177 | 8 | a4ecac6ee8a0d4d85319104c179ec7711a3efb51 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-T_mait|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.27e-06 | 197 | 177 | 8 | 653f5cfc44bc3b9218fa187df3d1d828070c2d44 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-06 | 198 | 177 | 8 | ff57addcbdd53e5d2d0c80ec76b5eab3b3a67ca2 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-06 | 198 | 177 | 8 | 698166b4ca173176ed563af6a1efc8c7d0a18e0b | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-06 | 198 | 177 | 8 | abac765c4f6864bdb1700bc546c3b9771edc25c3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.37e-06 | 199 | 177 | 8 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 1.37e-06 | 199 | 177 | 8 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.37e-06 | 199 | 177 | 8 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-06 | 199 | 177 | 8 | 036776a03fdd181e51cc655ed99331eec9c63f39 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 177 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.42e-06 | 200 | 177 | 8 | be9a43acc2f926b9433ab3f018b911b03896a924 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.42e-06 | 200 | 177 | 8 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 177 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.42e-06 | 200 | 177 | 8 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 177 | 8 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 177 | 8 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.42e-06 | 200 | 177 | 8 | 66fb892bda1d29e67a65717e85f2ec221f520b2a | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 177 | 8 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 177 | 8 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-06 | 153 | 177 | 7 | 79c4f4ccdc8249c8461075c73491bc3b2d13344a | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.11e-06 | 163 | 177 | 7 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.02e-06 | 168 | 177 | 7 | 9d6ca10c272aea28082c09d469940f7232f6461c | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.22e-06 | 169 | 177 | 7 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-06 | 169 | 177 | 7 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.22e-06 | 169 | 177 | 7 | 01a24a8817628125bd004b2be68ffa62c7111f6e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-06 | 169 | 177 | 7 | 0bc8ef341ce307b19018d4ac8de0a4d04254209d | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.43e-06 | 170 | 177 | 7 | da4dde7d0491ccc298cec7474a6a76ff3db36a4c | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.86e-06 | 172 | 177 | 7 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.09e-06 | 173 | 177 | 7 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.32e-06 | 174 | 177 | 7 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-06 | 175 | 177 | 7 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-regulatory_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.81e-06 | 176 | 177 | 7 | 856a8c4211ea33d926b18d8959a03909562aa563 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.81e-06 | 176 | 177 | 7 | a4d269075aa0efc46fa251b379f334e50c69391d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.81e-06 | 176 | 177 | 7 | cc6f65a7d2c622841c9d1ab3755586039d4ccc4d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.81e-06 | 176 | 177 | 7 | e9152defb4fd41267fb33c42c01fd0c683280783 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.07e-06 | 177 | 177 | 7 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.07e-06 | 177 | 177 | 7 | d9c4a93b0e04a13bf39992dd1c1ec8df2c5f89fe | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.07e-06 | 177 | 177 | 7 | ac8f774596068e66c0a9ea8a318be0ce5f5df834 | |
| ToppCell | IIF-Lymphocyte-T_NK-MAIT|IIF / Disease, Lineage and Cell Type | 7.33e-06 | 178 | 177 | 7 | be777ebef8f09a1a16fcee8fc69a65ab295b6e1d | |
| Drug | Bethanechol chloride [590-63-6]; Up 200; 20.4uM; MCF7; HT_HG-U133A | IFT140 PARP8 GPR143 TEX15 PTCH1 TRIM14 ETAA1 KDM6A MUC6 PRLR NPAS1 | 4.04e-07 | 198 | 175 | 11 | 3537_UP |
| Drug | SC-560; Up 200; 10uM; MCF7; HT_HG-U133A | SP100 BMP2K LAMA3 BCL6 PTCH1 BCL9 CCDC88C IPO9 SHANK2 RNF146 | 2.83e-06 | 195 | 175 | 10 | 6913_UP |
| Disease | serum gamma-glutamyl transferase measurement | HNF1B ZEB1 NRBF2 KALRN ASH1L HDX LMTK2 EBF1 CSMD3 DCAF5 STAB1 KAT2B POM121 SSH1 NBEAL2 AKAP13 LRBA MUC6 | 9.15e-06 | 914 | 175 | 18 | EFO_0004532 |
| Disease | diffuse large B-cell lymphoma (is_marker_for) | 1.12e-05 | 8 | 175 | 3 | DOID:0050745 (is_marker_for) | |
| Disease | blood urea nitrogen measurement | HNF1B SYNPO2 GPRIN3 EBF1 PPARGC1A THBS3 MICALL2 LRP2 AKAP13 LRBA MBD5 PRLR | 1.78e-05 | 452 | 175 | 12 | EFO_0004741 |
| Disease | Malignant neoplasm of breast | KDM3A HHEX ZEB1 ANK2 KALRN ADAMTS1 PPM1E FRMPD1 TACC2 SLAMF1 NOP9 THBS3 NLRP14 EGF TLE3 MKI67 MMP1 LRBA | 7.54e-05 | 1074 | 175 | 18 | C0006142 |
| Disease | Junctional epidermolysis bullosa | 1.05e-04 | 3 | 175 | 2 | cv:C0079301 | |
| Disease | Junctional epidermolysis bullosa gravis of Herlitz | 1.05e-04 | 3 | 175 | 2 | cv:C0079683 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE | 1.05e-04 | 3 | 175 | 2 | 226700 | |
| Disease | hematocrit | HNF1B PITRM1 KALRN ASH1L EBF1 BCL6 STAB1 PPARGC1A THBS3 MICALL2 ACSBG1 LRP2 ANKRD17 CHRDL1 TRMT61B BSN ENG | 1.16e-04 | 1011 | 175 | 17 | EFO_0004348 |
| Disease | vital capacity | GDF5 NDST1 NRBF2 ADAMTS1 RBBP8 PCLO FRMPD1 GPRIN3 EBF1 PTCH1 KMT2E PKD1L3 LIN28A SVEP1 DST RTL9 CTNNA3 LRP2 LRBA | 1.46e-04 | 1236 | 175 | 19 | EFO_0004312 |
| Disease | parental longevity | ANK2 ADAMTS1 PCLO HDX PLXNB2 LRP1B SNX29 PPARGC1A TMTC1 TRAFD1 BSN | 1.89e-04 | 494 | 175 | 11 | EFO_0007796 |
| Disease | lung adenocarcinoma (is_implicated_in) | 2.06e-04 | 49 | 175 | 4 | DOID:3910 (is_implicated_in) | |
| Disease | Herlitz Disease | 2.08e-04 | 4 | 175 | 2 | C0079683 | |
| Disease | Epidermolysis Bullosa Progressiva | 2.08e-04 | 4 | 175 | 2 | C0079297 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 2.13e-04 | 91 | 175 | 5 | EFO_0004611, EFO_0005271 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.62e-04 | 148 | 175 | 6 | C0279702 | |
| Disease | retinal vasculature measurement | SLAMF1 GLCCI1 LUZP1 FBXL4 EBF2 MYOF KAT2B MB21D2 SH3PXD2A CTNNA3 KNL1 | 2.80e-04 | 517 | 175 | 11 | EFO_0010554 |
| Disease | cognitive function measurement, self reported educational attainment | 2.86e-04 | 355 | 175 | 9 | EFO_0004784, EFO_0008354 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.03e-04 | 152 | 175 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | ANK2 KALRN PARP8 PPM1E LAMB3 CSMD3 LIG1 CCNB3 MKI67 ETAA1 LRP2 MMP1 KDM6A | 3.04e-04 | 702 | 175 | 13 | C0009402 |
| Disease | urinary pH measurement | 3.46e-04 | 5 | 175 | 2 | EFO_0010136 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 3.46e-04 | 5 | 175 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 3.46e-04 | 5 | 175 | 2 | C2608084 | |
| Disease | esophageal disease | 3.46e-04 | 5 | 175 | 2 | EFO_0009544 | |
| Disease | hereditary sensory neuropathy (implicated_via_orthology) | 3.46e-04 | 5 | 175 | 2 | DOID:0050548 (implicated_via_orthology) | |
| Disease | Endometrial Stromal Sarcoma | 3.46e-04 | 5 | 175 | 2 | C0206630 | |
| Disease | chordin-like protein 1 measurement | 3.46e-04 | 5 | 175 | 2 | EFO_0020257 | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 3.46e-04 | 5 | 175 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 4.40e-04 | 163 | 175 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Clear cell sarcoma of kidney | 5.16e-04 | 6 | 175 | 2 | C0334488 | |
| Disease | Junctional Epidermolysis Bullosa | 5.16e-04 | 6 | 175 | 2 | C0079301 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 6.02e-04 | 28 | 175 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 7.20e-04 | 7 | 175 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | Amelogenesis imperfecta local hypoplastic form | 7.20e-04 | 7 | 175 | 2 | C0399367 | |
| Disease | cervical cancer (is_implicated_in) | 7.40e-04 | 30 | 175 | 3 | DOID:4362 (is_implicated_in) | |
| Disease | forced expiratory volume | GDF5 NRBF2 BMP2K RBBP8 EBF1 PTCH1 BCL9 PLXNB2 LIN28A SVEP1 DST SH3PXD2A RASGEF1C | 9.01e-04 | 789 | 175 | 13 | EFO_0004314 |
| Disease | cognitive function measurement | SYNPO2 ATXN7L2 KALRN PTCH1 KMT2E PKD1L3 CSMD3 PLXNB2 ZP3 LRP1B GLCCI1 SNX29 FBXL4 STAB1 IPO9 CTNNA3 KCNIP4 PRLR NPAS1 | 9.08e-04 | 1434 | 175 | 19 | EFO_0008354 |
| Disease | serum urea measurement | 1.12e-03 | 195 | 175 | 6 | EFO_0009795 | |
| Disease | intermittent Staphylococcus aureus carrier status | 1.23e-03 | 9 | 175 | 2 | EFO_0007758 | |
| Disease | tyrosine-protein phosphatase non-receptor type 4 measurement | 1.23e-03 | 9 | 175 | 2 | EFO_0802172 | |
| Disease | plexin-B2 measurement | 1.23e-03 | 9 | 175 | 2 | EFO_0021867 | |
| Disease | lifestyle measurement, systolic blood pressure | 1.23e-03 | 9 | 175 | 2 | EFO_0006335, EFO_0010724 | |
| Disease | sex interaction measurement, Crohn's disease | 1.37e-03 | 37 | 175 | 3 | EFO_0000384, EFO_0008343 | |
| Disease | sleep time | 1.53e-03 | 10 | 175 | 2 | EFO_0005274 | |
| Disease | testosterone measurement | HHEX SPEM3 NRBF2 ANK2 LAMB3 ZNF385B EBF1 SRCAP CSMD3 EBF2 KAT2B SH3PXD2A RTL9 CHRDL1 KCNIP4 PRLR KNL1 | 1.59e-03 | 1275 | 175 | 17 | EFO_0004908 |
| Disease | neuroimaging measurement, brain volume measurement | 1.66e-03 | 286 | 175 | 7 | EFO_0004346, EFO_0006930 | |
| Disease | renal fibrosis (biomarker_via_orthology) | 2.22e-03 | 12 | 175 | 2 | DOID:0050855 (biomarker_via_orthology) | |
| Disease | abdominal aortic aneurysm (is_implicated_in) | 2.22e-03 | 12 | 175 | 2 | DOID:7693 (is_implicated_in) | |
| Disease | unipolar depression | NOL4 ATXN7L2 PCLO ASH1L MC5R PTCH1 CSMD3 LIN28A SNX29 FBXL4 EBF2 TMTC1 IPO9 SHANK2 CTNNA3 CHD6 | 2.29e-03 | 1206 | 175 | 16 | EFO_0003761 |
| Disease | Neurodevelopmental Disorders | 2.32e-03 | 93 | 175 | 4 | C1535926 | |
| Disease | household income | 2.33e-03 | 304 | 175 | 7 | EFO_0009695 | |
| Disease | red blood cell density measurement | BMP2K KALRN RFX7 PPARGC1A KAT2B THBS3 NEUROD2 DST MICALL2 ACSBG1 TLE3 AKAP13 ENG | 2.37e-03 | 880 | 175 | 13 | EFO_0007978 |
| Disease | hyperglycemia (is_marker_for) | 2.61e-03 | 13 | 175 | 2 | DOID:4195 (is_marker_for) | |
| Disease | gallbladder cancer (is_implicated_in) | 2.61e-03 | 13 | 175 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 2.69e-03 | 398 | 175 | 8 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | serum albumin measurement | 2.93e-03 | 592 | 175 | 10 | EFO_0004535 | |
| Disease | aspartate aminotransferase measurement | MRC1 HNF1B KALRN GPRIN3 PTCH1 CHKB PPARGC1A IPO9 TRAFD1 KCNIP4 AKAP13 LTBR LRBA | 2.98e-03 | 904 | 175 | 13 | EFO_0004736 |
| Disease | opioid dependence | 2.99e-03 | 237 | 175 | 6 | EFO_0005611 | |
| Disease | atrial fibrillation (is_implicated_in) | 3.04e-03 | 14 | 175 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.09e-03 | 49 | 175 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | pancreatic cancer (is_marker_for) | 3.12e-03 | 101 | 175 | 4 | DOID:1793 (is_marker_for) | |
| Disease | glucose homeostasis measurement, glucose effectiveness measurement | 3.49e-03 | 15 | 175 | 2 | EFO_0006833, EFO_0006896 | |
| Disease | intraocular pressure measurement | 3.49e-03 | 509 | 175 | 9 | EFO_0004695 | |
| Disease | COVID-19, mortality | 3.52e-03 | 170 | 175 | 5 | EFO_0004352, MONDO_0100096 | |
| Disease | body weight | GDF5 HHEX HNF1B COPG1 HDX E2F7 EBF1 BCL6 PTCH1 LRP1B GLCCI1 EBF2 IPO9 MICALL2 CTNNA3 CHRDL1 | 3.54e-03 | 1261 | 175 | 16 | EFO_0004338 |
| Disease | uric acid measurement | 3.62e-03 | 610 | 175 | 10 | EFO_0004761 | |
| Disease | Schizoaffective disorder-bipolar type | 3.97e-03 | 16 | 175 | 2 | EFO_0009965 | |
| Disease | amygdala volume change measurement | 3.97e-03 | 16 | 175 | 2 | EFO_0021490 | |
| Disease | Lewy body measurement, Parkinson disease | 3.97e-03 | 16 | 175 | 2 | EFO_0007021, MONDO_0005180 | |
| Disease | Acute Cerebrovascular Accidents | 4.07e-03 | 54 | 175 | 3 | C0751956 | |
| Disease | respiratory symptom change measurement, response to placebo | 4.49e-03 | 17 | 175 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | neurofilament light chain measurement | 4.74e-03 | 57 | 175 | 3 | EFO_0009178 | |
| Disease | idiopathic pulmonary fibrosis | 4.74e-03 | 57 | 175 | 3 | EFO_0000768 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 4.74e-03 | 57 | 175 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | R-6-hydroxywarfarin measurement | 4.81e-03 | 114 | 175 | 4 | EFO_0803327 | |
| Disease | Neoplasm Invasiveness | 4.92e-03 | 184 | 175 | 5 | C0027626 | |
| Disease | Oral Submucous Fibrosis | 5.03e-03 | 18 | 175 | 2 | C0029172 | |
| Disease | level of Sphingomyelin (d34:1) in blood serum | 5.03e-03 | 18 | 175 | 2 | OBA_2045175 | |
| Disease | Carcinoma of bladder | 5.03e-03 | 18 | 175 | 2 | C0699885 | |
| Disease | breast cancer (is_marker_for) | 5.03e-03 | 185 | 175 | 5 | DOID:1612 (is_marker_for) | |
| Disease | neuroblastoma | 5.11e-03 | 116 | 175 | 4 | EFO_0000621 | |
| Disease | adverse effect, response to xenobiotic stimulus | 5.23e-03 | 59 | 175 | 3 | EFO_0009658, GO_0009410 | |
| Disease | forced expiratory volume, response to bronchodilator | 5.25e-03 | 445 | 175 | 8 | EFO_0004314, GO_0097366 | |
| Disease | platelet component distribution width | SCN11A BMP2K KALRN TRMO CHKB DCAF5 SVEP1 EGF C22orf31 AKAP13 LTBR | 5.59e-03 | 755 | 175 | 11 | EFO_0007984 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PTQEPLKASCSTNIN | 431 | Q9NR48 | |
| VNCSDPGIPANSKRE | 2931 | Q7Z407 | |
| RKASDGNCTLPKDSP | 536 | Q99708 | |
| CAPAASSLDGNKPAE | 536 | Q12802 | |
| ALNCSQPSPLDVGVK | 1056 | Q12802 | |
| KKSCGNRNETPSDPV | 166 | Q9HAK2 | |
| CAKQNINAPAPATTS | 46 | O95567 | |
| PGSPVCRADKAKSQQ | 146 | Q86VQ1 | |
| QPISAPLFSCPDKNK | 436 | Q86VQ1 | |
| KTAQDPGISPSQSLC | 156 | Q9BSQ5 | |
| SRNSPLDCGSASPNK | 2056 | O75179 | |
| DGLQQSKCPDTTPKR | 21 | Q9Y259 | |
| KDCPVSNINNSSIPS | 321 | Q9NSY1 | |
| CASRSKSGEEDPQPQ | 146 | P00736 | |
| PVAFPTGDANSLCKS | 531 | Q9Y485 | |
| AAKGNCVSLLSPSPE | 511 | P17813 | |
| AGQKLSESPASLPSC | 1256 | Q2TAZ0 | |
| KDNLCQPGGLTKDSP | 166 | Q5T6C5 | |
| SSSNDCPPELKNLHL | 311 | Q96QP1 | |
| CESASDKPVSPQAKG | 1091 | Q8WWL7 | |
| PKVDDQCGNSSSIPF | 336 | Q5T7V8 | |
| FQCLSAKASPQDPLK | 1501 | Q149M9 | |
| GQPASECAKEVKPAS | 886 | Q9UHI8 | |
| APSGPCLQAQRKEKS | 36 | Q99742 | |
| SNGREPKAPTSDKCL | 621 | Q9HCC9 | |
| PKDTSPKRQDDCTGS | 2316 | Q01484 | |
| SPATPSNCKLLLSEN | 106 | Q8N635 | |
| CSQDLNSRVKPGFPK | 26 | O76096 | |
| RLKDSPQTAPDKGQC | 31 | Q6W4X9 | |
| SSEAQKTPAQECKPA | 231 | Q86U38 | |
| SSSQLAPNGAKCIPV | 471 | Q8N3A8 | |
| AQLKLSSCPSGRQPA | 261 | P43026 | |
| NAPQKPSSAEGNCLS | 281 | Q7Z353 | |
| DEAPLNPKCKSAEQS | 2876 | Q9NZR2 | |
| PTANKAASLGCNNKP | 6 | Q8IYB1 | |
| AASLGCNNKPAFPEL | 11 | Q8IYB1 | |
| LTGDCINQEPKDSSP | 1801 | Q16787 | |
| PKSLPTNSFVGCLKN | 3116 | Q16787 | |
| SSPACKASSGLEANP | 411 | Q92831 | |
| NKGASLDSSQCSPSP | 226 | Q03014 | |
| PESNGNKCEAPALSF | 2246 | Q03001 | |
| NGLSNSSILLDKCPP | 906 | O15550 | |
| IPKNPASNDSCPALE | 616 | Q9HDC5 | |
| CPALEKEANSGPNSI | 626 | Q9HDC5 | |
| PLCQAELNVGSKSPA | 466 | Q9UPA5 | |
| SGPEACKQESPQKLG | 1816 | Q9P219 | |
| NPANTNCLTASKSAP | 131 | P40925 | |
| CSPQKAQEANKARPS | 271 | Q8IY33 | |
| LNIGSKDPPNFNTCT | 1066 | Q9Y6V0 | |
| QVATGPALDNKKCTP | 66 | O15031 | |
| GKNPKPCSEAASSQK | 1431 | Q9H792 | |
| CPDVQASLPDAKAKS | 196 | Q96PD5 | |
| PSPKSQDKISQSFCD | 71 | A0A1B0GTH6 | |
| FPENDKQQASPSCPK | 811 | Q8IXT1 | |
| IAELCASAQKPPSLN | 351 | Q8N819 | |
| LPCSAAKTSSPAIQN | 41 | Q6PIL6 | |
| NCIPGSADFQSLVPK | 266 | O60229 | |
| NPAPSSSKEACLNIA | 701 | Q96JK2 | |
| KISDPATCAGLVPSN | 291 | Q96JB8 | |
| SNLGLKDCSINPKSP | 191 | P52848 | |
| GLSTDPIKLPCNSEN | 1236 | Q5T7B8 | |
| ENKSPLLLNDSCSLP | 851 | Q8IZD2 | |
| TDAQLCLESSPKDNP | 426 | P50851 | |
| KDNGTFSCAVKNPPD | 121 | Q6UWV2 | |
| NSSAPICENKPKILN | 1506 | Q8NG31 | |
| PAAQDSCLEARKSQP | 1146 | Q8IWU2 | |
| ATGFKLNPDNRSCSP | 2046 | P98164 | |
| PEPLSNSCQISKEGR | 311 | Q9UQ07 | |
| AAKQPSDKCSASPPL | 816 | P46013 | |
| PEPLCSDSSQGQKAE | 771 | Q2PPJ7 | |
| SKKPASAVLTCPNAS | 1221 | Q6ZV29 | |
| QQKSEPAEPCIGSKA | 146 | Q96F24 | |
| QPPTAALCSKSNPEE | 61 | Q9NY74 | |
| SPVCSGLENEQFKSP | 646 | Q8WY54 | |
| QDNPFRASPKLKSSC | 306 | Q9UBK2 | |
| ISGPNKDKFCPSTVN | 971 | Q9UHC9 | |
| LSSPSSNAPDPCAKE | 296 | Q96HA1 | |
| TLVNCPQNPSSRKKG | 36 | Q9UI47 | |
| VPPQACKAPSSNTDL | 896 | O14976 | |
| SPSNPLQELGNTCQK | 391 | O43313 | |
| PKGSCTQPKTNTDQE | 386 | Q9Y4C1 | |
| SDSPNNCSGKKVEPS | 461 | Q9Y4C1 | |
| EPDCPSSSANSRKDK | 271 | Q96AV8 | |
| DSLPPVNNKVTSKSC | 101 | Q9BU40 | |
| LDEKSCAASGPQPFL | 471 | P01133 | |
| EAKCLASPSLNPGNE | 1806 | Q8TD26 | |
| PNLQALNLSSCDKLP | 401 | Q9UKA2 | |
| LNLSSCDKLPPQAFN | 406 | Q9UKA2 | |
| QGSPLETPRSSAKQC | 131 | Q5T0N1 | |
| QNKASTSSPENSLPC | 801 | Q5SYB0 | |
| NSADLPESTLLPNKC | 451 | Q86XJ1 | |
| SNLPQSSADAALCKP | 1181 | O00512 | |
| SESCNKNEGDPALPT | 386 | P51810 | |
| PSILNQDNKTCSLPG | 481 | P06756 | |
| QNLTCPGSDLKPFTT | 411 | Q96GR2 | |
| DKKSCGNRNETPSDP | 166 | Q9UH73 | |
| KGLVSPQSPQKSDCQ | 326 | P41182 | |
| KNACILQASGSPPAK | 351 | P41182 | |
| NGLEADNSCPNSKAP | 586 | Q86V48 | |
| NKASGLPPTESNCEV | 541 | Q7KZI7 | |
| QGKECSNTSDALDPP | 101 | Q6UX82 | |
| ALDPPLKNVSSNAEC | 111 | Q6UX82 | |
| LSGPNVKNKSSPCED | 21 | P33032 | |
| NAKSVNGCVPSPSDA | 1341 | Q9P267 | |
| QAPADKIPAGLCATA | 656 | Q96P70 | |
| SLPDLTPTFNKLCGN | 776 | Q13751 | |
| NLPGCSAKELAPAVS | 276 | Q9Y678 | |
| PRSSLEACKAAGQAP | 6 | A6NKP2 | |
| DKKSCGNRNETPSDP | 166 | Q9H4W6 | |
| KPLTRESGCSENKQP | 236 | Q6ZVF9 | |
| SPAKGQKPALDCSQV | 76 | P18858 | |
| ILPSKADNSPDSKIC | 586 | Q96RY7 | |
| ASDNGTACPAPKLQV | 2076 | Q8TDX9 | |
| SNNSLPCGSPKKCNL | 1021 | Q5THK1 | |
| APRKAQDPSSAGCDQ | 1491 | Q5THK1 | |
| EPGKSCVSLNPGKNA | 311 | P22897 | |
| PGQSDDACSEPTNKK | 216 | P35680 | |
| LASSQAKAPPDDSCN | 311 | Q8IVF1 | |
| LASSQAKAPPDDSCN | 311 | A6NNL0 | |
| SSQAKAPPDDSCNPR | 241 | Q5VT03 | |
| LASSQAKAPPDDSCN | 311 | B1AL46 | |
| DSPGNSSQVLPTACK | 1316 | Q8NET4 | |
| NSPNCTDPKLLNGSV | 181 | P23975 | |
| ESPEKPLEGNTCLSQ | 371 | Q8TEQ0 | |
| NACSDNELPLPSSPK | 571 | Q8WXA3 | |
| DTKQETANGPTSCLP | 436 | O14545 | |
| AALCPSPKVSSNQLN | 226 | Q8N6T0 | |
| GPQTPKACDSKLTFD | 271 | P03956 | |
| EPDDKNQEPSSCKSL | 176 | Q9GZU8 | |
| CSSSESQPLQPQKIK | 66 | Q5VWT5 | |
| LAQKSEIPKCSNSPG | 81 | Q5VWT5 | |
| PQACKNNICLDLSPS | 851 | Q6ZNJ1 | |
| SQQSKPQDASCLPAL | 546 | Q5JRX3 | |
| KCSSSVPGSRDKNNP | 1241 | Q7Z443 | |
| DPDCPATAPNKNSTK | 301 | Q13635 | |
| QKKLDSFPAQDPCTT | 291 | Q13291 | |
| SLPVAPAACEALNKN | 36 | O95475 | |
| SSSSSNQKAPLPCPQ | 176 | Q8NDZ2 | |
| LPSNNCTKNVSPLSK | 136 | Q6ZNX1 | |
| CDNNIKSKTLPDIPS | 176 | Q562F6 | |
| PTNRKANESCSNTAP | 16 | Q9NTX7 | |
| SSLKQPSTEKNELCP | 226 | O75626 | |
| LDPENPTKSCKSRGS | 6 | P18621 | |
| LNQPLTSSKAGSSPC | 251 | Q6ZRS2 | |
| EPVKCSSPENINNGK | 1901 | Q4LDE5 | |
| DFTCNPLNSISEPKG | 441 | Q86YF9 | |
| ESAPADKQCKPEATQ | 516 | O94818 | |
| GKALIQTCLNSPDSP | 211 | P11831 | |
| DSKKPASLSNCLPAS | 1461 | Q9UPX8 | |
| LLKNSHCDKNPPSTE | 756 | Q8WYL5 | |
| CVPNNLKTLIPNASS | 241 | Q9UPZ9 | |
| CASPPSLTSANKKNF | 406 | Q86XZ4 | |
| LESCFSAKNGTPRQP | 36 | Q9BU70 | |
| STPSLNKPPCAAAAL | 351 | Q6ZU65 | |
| AAQRKAPGAESCPSL | 56 | Q9BVS5 | |
| QDKSSNGALCPRSPQ | 241 | Q8IUR5 | |
| CKSIALLLTDAPNPN | 376 | Q9UMS6 | |
| EKLDAEPKPCSDTNS | 1006 | Q13129 | |
| QESKTKTPDCAPAEA | 191 | A0A1B0GUW6 | |
| DANAGLTSCPRAKPS | 741 | Q5TCZ1 | |
| QAFVNKDPLASTKPC | 226 | Q8N431 | |
| NPDSNSANCLEEKGP | 41 | P10124 | |
| SGSQPQEPENKKCSC | 476 | P23497 | |
| DTCPTLPKLTNNCSD | 6 | Q6ZNM6 | |
| QDPSSSPLEKCLGSA | 11 | Q5VUG0 | |
| SPSLLSEKCEEPQAN | 356 | P16471 | |
| DLAPQTISDKSKCAP | 1166 | Q6P2S7 | |
| LSLSLNQQPAAPECK | 301 | Q86W42 | |
| ALNTSTCPPNSVKLD | 671 | Q9NY15 | |
| SGLQPKCPDTLQSRE | 691 | O95359 | |
| SPPNGDSINKDPKLC | 541 | Q2KHR2 | |
| KDSAKANPSCSITPI | 201 | Q569K4 | |
| LPSQDEGPSKAFVNC | 506 | P01833 | |
| KDNCPQLPNSSQLDS | 636 | P49746 | |
| QPGSKSPISQLDCLN | 516 | Q04726 | |
| NPVATNSCKSEKLPE | 496 | P37275 | |
| PGTAQSDTTCKNPLE | 201 | P36941 | |
| NCQLSDPSSTKPGTL | 236 | Q14142 | |
| SSQPIKESNSLCPAG | 1351 | Q9UPU5 | |
| SFNSQKSPKLCNPTG | 726 | Q9UI33 | |
| ETLCTKNLKSNPDQP | 1346 | Q6PGP7 | |
| LLKKNNSCSPAGPSN | 96 | Q9H0W7 | |
| NSCSPAGPSNLKSNI | 101 | Q9H0W7 | |
| GSLLPLENPKDTCAS | 2396 | Q9BXT5 | |
| LKNSPDPTQKSCLSD | 2481 | Q9BXT5 | |
| LSSPSSNAPDPCAKE | 31 | Q6PJE2 | |
| PDELNKACSFSKPSN | 131 | Q6PJE2 | |
| QDPDELNKACSFSKP | 291 | P21754 | |
| ATSPFLPKKANDNSN | 146 | Q499Y3 | |
| SSPGNKDKEAPCSRE | 306 | O15231 | |
| KEGCEPQSASPQSKE | 136 | Q9HCK0 | |
| SSPNGTAFPAAECLK | 316 | Q8TEU8 | |
| VASCPLKAQQGPSAQ | 171 | Q9H9Z2 | |
| GNPSCQPFEDLKSLL | 501 | Q86W24 | |
| ANGDKAASPSELTCP | 956 | Q9NZM1 | |
| PPLCLNGNFSLKQDS | 301 | Q15784 |